AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20158295 — intervention group
Group type: EXPERIMENTAL
Intervention: External smoking cue (pictures of cigarettes)
Number of subjects: 175
Study 20158295 — intervention group
Group type: EXPERIMENTAL
Intervention: Both types of cues
Number of subjects: 175
Study 20158295 — intervention group
Group type: EXPERIMENTAL
Intervention: Impulsivity measures
Number of subjects: 175
Study 18677177 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified preventive care involving a practice nurse, peer health educator, GP, and GP assistant
Number of subjects: 275
Study 18677177 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 275
Study 15952024 — intervention group
Group type: COMPARATOR
Intervention: Control temperature (34.2 ± 0.3 degrees C)
Number of subjects: 20
Study 15952024 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold temperature (31.3 ± 0.5 degrees C)
Number of subjects: 20
Study 15952024 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm temperature (37.1 ± 0.2 degrees C)
Number of subjects: 20
Study 12182909 — intervention group
Group type: EXPERIMENTAL
Intervention: front-loaded rt-PA (up to 100 mg)
Number of subjects: 30
Study 12182909 — intervention group
Group type: EXPERIMENTAL
Intervention: TNK-tPA (single bolus up to 50 mg)
Number of subjects: 30
Study 10469772 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.25 mg/kg on days 1-7, 0.12 mg/kg on days 8-14, 0.05 mg/kg on days 15-21, 0.02 mg/kg on days 21-28)
Number of subjects: 179
Study 10469772 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 179
Study 8733214 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired Associate Learning Test (PALT)
Number of subjects: 2584
Study 1725549 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium blockers (diltiazem)
Number of subjects: 0
Study 1725549 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium antagonists (dihydropiridines)
Number of subjects: 0
Study 1725549 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme (ACE) inhibitors
Number of subjects: 0
Study 1725549 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium blockers and ACE inhibitors
Number of subjects: 0
Study 6218948 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg levamisole once weekly
Number of subjects: 21
Study 6218948 — intervention group
Group type: EXPERIMENTAL
Intervention: 350 mg daily doses of levamisole for 3 consecutive days weekly
Number of subjects: 21
Study 6218948 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 31448876 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training plus postural or positional inversion exercises
Number of subjects: 40
Study 31448876 — intervention group
Group type: COMPARATOR
Intervention: Pelvic floor muscle training (control)
Number of subjects: 40
Study 31448876 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (baseline comparison)
Number of subjects: 40
Study 31453722 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehospital vulnerability (VES ≥ 3)
Number of subjects: 301
Study 26940357 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant stanol ester enriched margarines (3.0g/d plant stanols)
Number of subjects: 13
Study 26577415 — intervention group
Group type: COMPARATOR
Intervention: Maternal diabetes exposure (either pre-pregnancy diabetes or gestational diabetes)
Number of subjects: 632
Study 26577415 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-exposure to maternal diabetes
Number of subjects: 632
Study 25076474 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.45% ketorolac tromethamine + carboxymethylcellulose
Number of subjects: 50
Study 25076474 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears alone
Number of subjects: 50
Study 22385563 — intervention group
Group type: EXPERIMENTAL
Intervention: Amygdala retraining along with standard care
Number of subjects: 44
Study 22385563 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 44
Study 20565997 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy turnover (HET)
Number of subjects: 13
Study 20565997 — intervention group
Group type: COMPARATOR
Intervention: Low energy turnover (LET)
Number of subjects: 13
Study 17906163 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil (5 mg/d) with doxazosin (1, 2, and 4 mg/d)
Number of subjects: 84
Study 17906163 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil (5 mg/d) with tamsulosin (0.4 mg/d)
Number of subjects: 84
Study 17906163 — intervention group
Group type: COMPARATOR
Intervention: Placebo with doxazosin (4 mg/d)
Number of subjects: 84
Study 17906163 — intervention group
Group type: COMPARATOR
Intervention: Placebo with tamsulosin (0.4 mg/d)
Number of subjects: 84
Study 17906163 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil alone
Number of subjects: 84
Study 17906163 — intervention group
Group type: COMPARATOR
Intervention: Doxazosin (4 mg/d) with placebo
Number of subjects: 84
Study 16140675 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment 0.03%
Number of subjects: 317
Study 16140675 — intervention group
Group type: COMPARATOR
Intervention: Vehicle ointment
Number of subjects: 317
Study 12186264 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 0
Study 9451062 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.2% saline solution
Number of subjects: 20
Study 9451062 — intervention group
Group type: COMPARATOR
Intervention: gelatin
Number of subjects: 20
Study 7658056 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized pentamidine, 300 mg every month
Number of subjects: 196
Study 7658056 — intervention group
Group type: COMPARATOR
Intervention: Dapsone, 50 mg/day
Number of subjects: 196
Study 2684251 — intervention group
Group type: EXPERIMENTAL
Intervention: Extradural clonidine (EC) 2 micrograms kg‐1 in isotonic saline solution 15 micrograms ml‐1
Number of subjects: 20
Study 2684251 — intervention group
Group type: COMPARATOR
Intervention: Extradural saline (ES) equivalent volume of plain isotonic saline solution
Number of subjects: 20
Study 2684251 — intervention group
Group type: EXPERIMENTAL
Intervention: Extradural clonidine (EC)
Number of subjects: 20
Study 2684251 — intervention group
Group type: COMPARATOR
Intervention: Extradural saline (ES)
Number of subjects: 20
Study 29654849 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 371
Study 29654849 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin + Rosiglitazone
Number of subjects: 371
Study 29654849 — intervention group
Group type: COMPARATOR
Intervention: Rosiglitazone
Number of subjects: 371
Study 29654849 — intervention group
Group type: COMPARATOR
Intervention: Insulin regimens (short or long-acting)
Number of subjects: 371
Study 29654849 — intervention group
Group type: COMPARATOR
Intervention: HbA1c
Number of subjects: 371
Study 29654849 — intervention group
Group type: COMPARATOR
Intervention: Overall BTMs
Number of subjects: 371
Study 28830529 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine
Number of subjects: 52
Study 28830529 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical MB-PDT
Number of subjects: 52
Study 28830529 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouthwash MB-PDT
Number of subjects: 52
Study 28830529 — intervention group
Group type: COMPARATOR
Intervention: Mechanical cleaning with filtered water
Number of subjects: 52
Study 25381858 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS + HDM
Number of subjects: 32
Study 25381858 — intervention group
Group type: COMPARATOR
Intervention: HDM
Number of subjects: 32
Study 23426461 — intervention group
Group type: EXPERIMENTAL
Intervention: teduglutide (0.5 mg/kg/d)
Number of subjects: 83
Study 23426461 — intervention group
Group type: EXPERIMENTAL
Intervention: teduglutide (0.10 mg/kg/d)
Number of subjects: 83
Study 23426461 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 83
Study 22015086 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 63
Study 22015086 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 63
Study 18545055 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (10-20 mg/day)
Number of subjects: 564
Study 18545055 — intervention group
Group type: COMPARATOR
Intervention: Duloxetine (60 mg/day)
Number of subjects: 564
Study 16298087 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 1000mg
Number of subjects: 17
Study 16298087 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 2000mg
Number of subjects: 17
Study 16298087 — intervention group
Group type: COMPARATOR
Intervention: Gabapentin 0mg (Control)
Number of subjects: 17
Study 12882844 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist nurse-led clinics for hypertension and hyperlipidemia
Number of subjects: 1407
Study 12882844 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist nurse-led clinic for hyperlipidemia
Number of subjects: 1407
Study 12882844 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist nurse-led clinic for hypertension
Number of subjects: 1407
Study 12882844 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist nurse-led clinics (enrolled to either or both clinics)
Number of subjects: 1407
Study 12882844 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1407
Study 10892359 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive surgical treatments for acute myocardial infarction
Number of subjects: 0
Study 10892359 — intervention group
Group type: COMPARATOR
Intervention: Insurance subpopulations
Number of subjects: 0
Study 9001926 — intervention group
Group type: EXPERIMENTAL
Intervention: Metered Dose Inhaler (MDI) - nedocromil sodium 4 mg + salbutamol 0.2 mg
Number of subjects: 12
Study 9001926 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulizer Solution - nedocromil sodium 10 mg + salbutamol 1.5 mg
Number of subjects: 12
Study 9001926 — intervention group
Group type: EXPERIMENTAL
Intervention: Metered Dose Inhaler (MDI)
Number of subjects: 12
Study 9001926 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulizer Solution
Number of subjects: 12
Study 1453242 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccination program
Number of subjects: 500
Study 6424240 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily topical applications of povidone‐iodine
Number of subjects: 179
Study 6424240 — intervention group
Group type: COMPARATOR
Intervention: Dry dressing changes
Number of subjects: 179
Study 6424240 — intervention group
Group type: EXPERIMENTAL
Intervention: CVCs in place for 0 to 7 days
Number of subjects: 179
Study 6424240 — intervention group
Group type: EXPERIMENTAL
Intervention: CVCs in place for 8 to 30 days
Number of subjects: 179
Study 29933269 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity simulation training (6 hours)
Number of subjects: 50
Study 29933269 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional training)
Number of subjects: 50
Study 29273946 — intervention group
Group type: EXPERIMENTAL
Intervention: Project Bridge (PB), an intensive case‐management intervention
Number of subjects: 0
Study 29273946 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU), standard referral to treatment
Number of subjects: 0
Study 26221051 — intervention group
Group type: EXPERIMENTAL
Intervention: Theta Burst Transcranial Magnetic Stimulation (TB‐rTMS)
Number of subjects: 71
Study 26221051 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (sham)
Number of subjects: 71
Study 26221051 — intervention group
Group type: EXPERIMENTAL
Intervention: TB‐rTMS
Number of subjects: 71
Study 24316509 — intervention group
Group type: EXPERIMENTAL
Intervention: Yamamoto's acupuncture method (5 sessions)
Number of subjects: 80
Study 24316509 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (5 non-penetrating sessions)
Number of subjects: 80
Study 23185756 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal enema therapy (CHET), once daily for 2 weeks as one therapeutic course
Number of subjects: 84
Study 23185756 — intervention group
Group type: COMPARATOR
Intervention: Basic treatment (control group)
Number of subjects: 84
Study 23185756 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal enema therapy (CHET)
Number of subjects: 84
Study 23185756 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal enema therapy (CHET) and basic treatment
Number of subjects: 84
Study 20397286 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion XL 300 mg
Number of subjects: 30
Study 20397286 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 17907089 — intervention group
Group type: EXPERIMENTAL
Intervention: Vessel sealing
Number of subjects: 150
Study 17907089 — intervention group
Group type: COMPARATOR
Intervention: Suture ligation
Number of subjects: 150
Study 16335686 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese women with diabetes type 2 (group A)
Number of subjects: 46
Study 16335686 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin treatment (subgroup AII)
Number of subjects: 46
Study 16335686 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfonylurea treatment (subgroup AI)
Number of subjects: 46
Study 16335686 — intervention group
Group type: COMPARATOR
Intervention: Obese women without additional disease (group B)
Number of subjects: 46
Study 11866674 — intervention group
Group type: EXPERIMENTAL
Intervention: Triptans (specifically sumatriptan)
Number of subjects: 0
Study 11866674 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Life (QOL) measures
Number of subjects: 0
Study 11866674 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparative pharmacoeconomic analyses of triptans
Number of subjects: 0
Study 10890232 — intervention group
Group type: EXPERIMENTAL
Intervention: Transposition of the greater omentum into the thorax
Number of subjects: 0
Study 10890232 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoglobulins
Number of subjects: 0
Study 7787918 — intervention group
Group type: EXPERIMENTAL
Intervention: Music-listening group
Number of subjects: 20
Study 7787918 — intervention group
Group type: COMPARATOR
Intervention: Nonmusic (headphones only) group
Number of subjects: 20
Study 2403227 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mL influenza vaccine
Number of subjects: 29
Study 2403227 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 mL influenza vaccine
Number of subjects: 29
Study 2403227 — intervention group
Group type: COMPARATOR
Intervention: 0.5 mL influenza vaccine
Number of subjects: 29
Study 2403227 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mL and 0.05 mL influenza vaccine
Number of subjects: 29
Study 630187 — intervention group
Group type: EXPERIMENTAL
Intervention: ioglycamide (Biligram) at 3 mg/kg/min for one hour
Number of subjects: 80
Study 630187 — intervention group
Group type: EXPERIMENTAL
Intervention: ioglycamide (Biligram) at 4 mg/kg/min for one hour
Number of subjects: 80
Study 630187 — intervention group
Group type: COMPARATOR
Intervention: ioglycamide (Biligram) at 2 mg/kg/min drip infusion
Number of subjects: 80
Study 630187 — intervention group
Group type: COMPARATOR
Intervention: ioglycamide (Biligram) by 10 minute slow hand injection
Number of subjects: 80
Study 31994819 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical therapy (control group)
Number of subjects: 458
Study 31596419 — intervention group
Group type: EXPERIMENTAL
Intervention: Scenarios with debriefing (experimental group)
Number of subjects: 120
Study 31596419 — intervention group
Group type: COMPARATOR
Intervention: Scenarios without debriefing (control group)
Number of subjects: 120
Study 28632975 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminders, encouragement, and educational messages delivered by mobile phone for 2 weeks
Number of subjects: 0
Study 28632975 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no messages)
Number of subjects: 0
Study 26690683 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% HES 130/0.4
Number of subjects: 826
Study 26690683 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 826
Study 23262808 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage intervention (multimedia instructional program including a 78-min DVD and 66-page manual)
Number of subjects: 97
Study 23262808 — intervention group
Group type: COMPARATOR
Intervention: Attention control (reading to patients)
Number of subjects: 97
Study 23262808 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage intervention (multimedia instructional program)
Number of subjects: 97
Study 21460356 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxabact (oral administration)
Number of subjects: 43
Study 21460356 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 18087163 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab at a dose of >=0.016 mg/kg/IgE every 4 weeks
Number of subjects: 17
Study 18087163 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 18087163 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 17
Study 16291387 — intervention group
Group type: EXPERIMENTAL
Intervention: PCEA (ropivacaine 3.2 mg + fentanyl 8 microg/dose)
Number of subjects: 70
Study 16291387 — intervention group
Group type: COMPARATOR
Intervention: IV-PCA (morphine 2 mg/dose)
Number of subjects: 70
Study 16291387 — intervention group
Group type: EXPERIMENTAL
Intervention: PCEA
Number of subjects: 70
Study 16291387 — intervention group
Group type: COMPARATOR
Intervention: IV-PCA
Number of subjects: 70
Study 12002503 — intervention group
Group type: COMPARATOR
Intervention: Manipulation (MUA) and application of an above-elbow cast alone
Number of subjects: 68
Study 12002503 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Kirschner (K-) wire insertion in addition to manipulation and casting
Number of subjects: 68
Study 10460982 — intervention group
Group type: EXPERIMENTAL
Intervention: 14‐day training of a relaxation therapy including a 30‐minute lullaby‐like, rhythmically dominated music with gradually decreasing tempi
Number of subjects: 28
Study 10460982 — intervention group
Group type: COMPARATOR
Intervention: No training in the control group
Number of subjects: 28
Study 8529732 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral diclofenac 50 mg 3 times a day for 7 days
Number of subjects: 80
Study 8529732 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 1695232 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous challenge with pollen antigens for 6 hours
Number of subjects: 11
Study 1695232 — intervention group
Group type: EXPERIMENTAL
Intervention: Interrupted challenge with pollen antigens (Ag) for 1 hour, buffer for 4 hours, then Ag during the sixth hour
Number of subjects: 11
Study 1695232 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous challenge with codeine (C) for up to 5 hours
Number of subjects: 11
Study 619075 — intervention group
Group type: EXPERIMENTAL
Intervention: Cendehill vaccine
Number of subjects: 113
Study 619075 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV‐77 vaccine
Number of subjects: 113
Study 619075 — intervention group
Group type: EXPERIMENTAL
Intervention: RA‐27/3 vaccine (subcutaneously)
Number of subjects: 113
Study 619075 — intervention group
Group type: EXPERIMENTAL
Intervention: RA‐27/3 vaccine (intranasally)
Number of subjects: 113
Study 619075 — intervention group
Group type: EXPERIMENTAL
Intervention: RA‐27/3 vaccine
Number of subjects: 113
Study 30917806 — intervention group
Group type: EXPERIMENTAL
Intervention: Loaded self-managed exercise programme
Number of subjects: 60
Study 30917806 — intervention group
Group type: COMPARATOR
Intervention: Usual physiotherapy
Number of subjects: 60
Study 28749550 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-high intensity combined resistance-endurance training for 6 months, 2 days per week
Number of subjects: 54
Study 28749550 — intervention group
Group type: COMPARATOR
Intervention: Usual care recommendations (Control Group)
Number of subjects: 54
Study 25832859 — intervention group
Group type: EXPERIMENTAL
Intervention: TCZ IV/SC
Number of subjects: 319
Study 25832859 — intervention group
Group type: COMPARATOR
Intervention: TCZ SC/SC
Number of subjects: 319
Study 23928094 — intervention group
Group type: EXPERIMENTAL
Intervention: BIIB023 (0.03-20 mg/kg)
Number of subjects: 38
Study 23928094 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 21318017 — intervention group
Group type: EXPERIMENTAL
Intervention: Handwashing with water
Number of subjects: 20
Study 21318017 — intervention group
Group type: EXPERIMENTAL
Intervention: Handwashing with non‐antibacterial soap and water
Number of subjects: 20
Study 21318017 — intervention group
Group type: COMPARATOR
Intervention: No handwashing
Number of subjects: 20
Study 19861525 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary PGE-M levels in gastric cancer cases
Number of subjects: 153
Study 19861525 — intervention group
Group type: COMPARATOR
Intervention: Urinary PGE-M levels in controls
Number of subjects: 153
Study 19861525 — intervention group
Group type: EXPERIMENTAL
Intervention: Quartiles of urinary PGE-M levels
Number of subjects: 153
Study 17545850 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib
Number of subjects: 1059
Study 17545850 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1059
Study 15318307 — intervention group
Group type: EXPERIMENTAL
Intervention: Indwelling dialysate in the peritoneal cavity
Number of subjects: 20
Study 15318307 — intervention group
Group type: EXPERIMENTAL
Intervention: No indwelling dialysate in the peritoneal cavity
Number of subjects: 20
Study 15318307 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 20
Study 11573658 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion at 2 microg ml(‐1) with two word lists (category examples and nonsense words)
Number of subjects: 36
Study 11573658 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion at 5 microg ml(‐1) with nonsense words before tracheal intubation and category examples during intubation
Number of subjects: 36
Study 11573658 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion at 5 microg ml(‐1) with category examples before and nonsense words during intubation
Number of subjects: 36
Study 11573658 — intervention group
Group type: COMPARATOR
Intervention: Control group (12 patients) completed the category generation test without receiving category examples during anaesthesia
Number of subjects: 36
Study 11573658 — intervention group
Group type: EXPERIMENTAL
Intervention: Category generation task during intubation
Number of subjects: 36